Common Contracts
8 similar Debt Conversion Agreement contracts by Hemoglobin Oxygen Therapeutics LLC
DEBT CONVERSION AGREEMENTDebt Conversion Agreement • April 26th, 2022 • Hemoglobin Oxygen Therapeutics LLC • Delaware
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of January 3, 2022, by and between Hemoglobin Oxygen Therapeutics, LLC., a Delaware limited liability company (the “Company”), and the undersigned creditor of the Company (“Purchaser”).
DEBT CONVERSION AGREEMENTDebt Conversion Agreement • April 26th, 2022 • Hemoglobin Oxygen Therapeutics LLC • Delaware
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of January 3, 2022, by and between Hemoglobin Oxygen Therapeutics, LLC., a Delaware limited liability company (the “Company”), and the undersigned creditor of the Company (“Purchaser”).
DEBT CONVERSION AGREEMENTDebt Conversion Agreement • April 26th, 2022 • Hemoglobin Oxygen Therapeutics LLC • Delaware
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of January 3, 2022, by and between Hemoglobin Oxygen Therapeutics, LLC., a Delaware limited liability company (the “Company”), and the undersigned creditor of the Company (“Purchaser”).
DEBT CONVERSION AGREEMENTDebt Conversion Agreement • April 26th, 2022 • Hemoglobin Oxygen Therapeutics LLC • Delaware
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of January 3, 2022, by and between Hemoglobin Oxygen Therapeutics, LLC., a Delaware limited liability company (the “Company”), and the undersigned creditor of the Company (“Purchaser”).
DEBT CONVERSION AGREEMENTDebt Conversion Agreement • April 26th, 2022 • Hemoglobin Oxygen Therapeutics LLC • Delaware
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of January 3, 2022, by and between Hemoglobin Oxygen Therapeutics, LLC., a Delaware limited liability company (the “Company”), and the undersigned creditor of the Company (“Purchaser”).
DEBT CONVERSION AGREEMENTDebt Conversion Agreement • April 26th, 2022 • Hemoglobin Oxygen Therapeutics LLC • Delaware
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of January 3, 2022, by and between Hemoglobin Oxygen Therapeutics, LLC., a Delaware limited liability company (the “Company”), and the undersigned creditor of the Company (“Purchaser”).
DEBT CONVERSION AGREEMENTDebt Conversion Agreement • April 26th, 2022 • Hemoglobin Oxygen Therapeutics LLC • Delaware
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of January 3, 2022 by and between Hemoglobin Oxygen Therapeutics, LLC., a Delaware limited liability company (the “Company”), and OVA International Investment LLC, a Washington limited liability company (“Purchaser”).
DEBT CONVERSION AGREEMENTDebt Conversion Agreement • April 26th, 2022 • Hemoglobin Oxygen Therapeutics LLC • Delaware
THIS DEBT CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of January 3, 2022, by and between Hemoglobin Oxygen Therapeutics, LLC., a Delaware limited liability company (the “Company”), and the undersigned creditor of the Company (“Purchaser”).
